|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/18/20 Centogene N.V. 6-K 3/18/20 2:25K Davis Polk & … LLP 01/FA |
Document/Exhibit Description Pages Size 1: 6-K Current Report by a Foreign Issuer HTML 9K 2: EX-99.1 Miscellaneous Exhibit HTML 12K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the date of March 18, 2020
Commission File Number 001-39124
Centogene N.V.
(Translation of registrant's name into English)
Am
Strande 7
18055 Rostock
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
C:
Centogene N.V.
On March 18, 2020, Centogene N.V. issued a press release titled “CENTOGENE Announces Commencement of Testing for COVID-19”.
A copy of the press release is attached hereto as Exhibit 99.1.
C:
C: 2
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CENTOGENE N.V. |
Date: March 18, 2020
| By: | /s/ Richard Stoffelen | ||
| Name: Richard Stoffelen | |||
|
|
Title: Chief Financial Officer
|
||
3
| Exhibit | Description of Exhibit |
| 99.1 | Press release dated March 18, 2020 |
C:
4
| This ‘6-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 3/18/20 | None on these Dates | ||
| List all Filings | ||||